BlackRock Fund Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.42B Buy
111,130,117
+7,806,087
+8% +$238M 0.63% 14
2016
Q3
$3.32B Buy
103,324,030
+2,754,787
+3% +$92.1M 0.68% 12
2016
Q2
$3.36B Buy
100,569,243
+3,085,709
+3% +$98.5M 0.74% 10
2016
Q1
$2.74B Buy
97,483,534
+1,479,443
+2% +$42.3M 0.63% 17
2015
Q4
$2.94B Buy
96,004,091
+5,979,870
+7% +$188M 0.68% 10
2015
Q3
$2.68B Buy
90,024,221
+969,691
+1% +$31.1M 0.69% 8
2015
Q2
$2.83B Sell
89,054,530
-2,384,440
-3% -$77.7M 0.68% 7
2015
Q1
$3.02B Buy
91,438,970
+1,248,563
+1% +$39.7M 0.72% 7
2014
Q4
$2.67B Buy
90,190,407
+2,284,885
+3% +$65.5M 0.66% 11
2014
Q3
$2.47B Buy
87,905,522
+2,819,010
+3% +$79.1M 0.7% 11
2014
Q2
$2.4B Buy
85,086,512
+818,003
+1% +$23.3M 0.67% 9
2014
Q1
$2.57B Buy
84,268,509
+10,109,763
+14% +$301M 0.76% 7
2013
Q4
$2.16B Sell
74,158,746
-4,661,688
-6% -$136M 0.66% 10
2013
Q3
$2.15B Buy
78,820,434
+1,435,145
+2% +$39M 0.73% 8
2013
Q2
$2.06B Buy
+77,385,289
New +$2.14B 0.75% 10

Other funds holding PFE

BlackRock Fund Advisors's PFE Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Pfizer (PFE) stake by 7.6% in Q4 2016, buying an estimated $238M and bringing the position to 111,130,117 shares worth $3.42B. The position accounts for 0.63% of the portfolio, ranked #14.

BlackRock Fund Advisors first reported a position in PFE in Q2 2013 and has held it in 15 quarters since. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

  • BlackRock Fund Advisors held 111,130,117 shares of Pfizer worth $3.42B as of Q4 2016.
  • BlackRock Fund Advisors bought 7,806,087 Pfizer shares in Q4 2016, an estimated $238M.
  • Pfizer made up 0.63% of BlackRock Fund Advisors's portfolio in Q4 2016, its #14 holding.
  • BlackRock Fund Advisors first reported a position in Pfizer in Q2 2013 and has held it in 15 quarters since.
  • 2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.